title: Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity.
authors.forename: François
authors.initials: F
authors.lastname: Raffi
authors.forename: Charlotte
authors.initials: C
authors.lastname: Lewden
authors.forename: Geneviève
authors.initials: G
authors.lastname: Chêne
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects; D004334:Drug Administration Schedule; D004342:Drug Hypersensitivity / Q000150:complications / Q000209:etiology / Q000401:mortality*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000401:mortality*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy / Q000401:mortality*; D006801:Humans; D015999:Multivariate Analysis; D019829:Nevirapine / Q000008:administration & dosage / Q000009:adverse effects; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine